Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Stroke|February 7, 2025
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 TrialMayank Goyal, Bijoy K Menon, Johanna Ospel, et al.
The New England Journal of Medicine|June 26, 2014
Atrial fibrillation in patients with cryptogenic strokeDavid J Gladstone, Melanie Spring, Paul Dorian, et al.
Stroke (Hoboken, N.J.)|May 8, 2026
AcT Trial: Protocol for a Pragmatic Registry-Linked Randomized Clinical TrialTolulope Sajobi, Nishita Singh, Mohammed A Almekhlafi, et al.
JAMA Neurology|July 10, 2023
Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical TrialFouzi Bala, Nishita Singh, Brian Buck, et al.
European Stroke Journal|April 23, 2026
Endovascular Acute Stroke Intervention-Tandem Occlusion (EASI-TOC) study: protocol and rationaleGeorge N Mendes, Grégory Jacquin, Daniela Iancu, et al.
Stroke|October 6, 2023
Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled TrialNishita Singh, Mohammed A Almekhlafi, Fouzi Bala, et al.
Stroke|August 6, 2025
Device-Detected Atrial Fibrillation in Patients With and Without Cryptogenic Ischemia: The ANTARCTICA Pooled AnalysisShadi Yaghi, Luciano A Sposato, Liqi Shu, et al.
European Stroke Journal|September 29, 2023
Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopeniaJohannes Weller, Katarzyna Krzywicka, Anita van de Munckhof, et al.
Lancet (London, England)|February 7, 2026
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialJoseph P Broderick, Andrew M Naidech, Jordan J Elm, et al.
Stroke|September 9, 2022
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute PhaseAnita van de Munckhof, Erik Lindgren, Timothy J Kleinig, et al.
Pageof 11